SCHEMBL22952996

SCHEMBL22952996

Oc1ccc2c(c1O)CC(c1ccnc(Cl)c1)C1CCNCC21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 6/20 0.65
DRD2 P14416 4/20 0.65
ADRA2A P08913 2/20 0.65
DRD5 P21918 2/20 0.65
DRD3 P35462 2/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
KDM4E B2RXH2 5/20 0.31
RECQL P46063 4/20 0.31
BLM P54132 3/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
NFKB1 P19838 2/20 0.31
THPO P40225 2/20 0.31
HIF1A Q16665 2/20 0.31
HSD17B10 Q99714 2/20 0.31
SLC6A3 Q01959 2/20 0.31
MAPT P10636 2/20 0.31
CYP1A2 P05177 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952932 0.89 ADRA2A (0.68) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952992 0.87 DRD1 (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952994 0.87 ADRA2A (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22953002 0.87 ADRA2A (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952936 0.85 DRD1 (0.63) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952993 0.85 ADRA2A (0.62) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952930 0.84 ADRA2A (0.78) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL611683 0.79 DRD1 (1.00) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22953348 0.79 ADRA2A (0.44) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952999 0.76 ADRA2A (0.45) DRD1DRD2ADRA2ADRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed